Indeed, Liu et al. concluded that circulating adiponectin might serve as an available diagnostic biomarker to identify metabolic syndrome subjects, especially in high-risk populations with insulin resistance [164]. This evidence concerns the gene ADIPOQ and Insulin resistance.